Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J. Data on the long-term outcome of nonalcoholic steatohepatitis (NASH)-associated cirrhosis are few, and most reports describe cases of cryptogenic cirrhosis associated with risk factors for NASH but without histologic definition. In this prospective cohort study, we describe the long-term morbidity and mortality of 23 patients with NASH-associated cirrhosis defined by strict clinicopathologic criteria. Outcomes were compared with 46 age- and gender-matched patients with cirrhosis from chronic hepatitis C virus (HCV) infection: 23 untreated and 23 nonresponders to antivir...
Recently, nonalcoholic steatohepatitis (NASH) has been considered to be another cause of liver cirrh...
BACKGROUND & AIMS Although patients with cryptogenic cirrhosis have historically been considered ...
The incidence of hepatocellular carcinoma (HCC) in the United States is increasing, but the clinical...
Data on the long-term outcome of nonalcoholic steatohepatitis (NASH)-associated cirrhosis are few, a...
The objective of this study was to prospectively define outcomes of cirrhosis due to nonal-coholic s...
Recently, nonalcoholic steatohepatitis (NASH) has been considered to be another cause of liver cirrh...
Non-alcoholic steatohepatitis (NASH) has been associated with hepatocellular carcinoma (HCC) often a...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging stages of sev...
Background: Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging s...
Introduction. Epidemiological studies indicate that nonalcoholic steatohepatitis (NASH) is a common ...
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome ...
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome ...
Non-alcoholic steatohepatitis (NASH) is growing into global problem, mainly due to NASH-induced cirr...
Background. Nonalcoholic fatty liver disease (NAFLD) may develop into liver cirrhosis and hepatocell...
Recently, nonalcoholic steatohepatitis (NASH) has been considered to be another cause of liver cirrh...
BACKGROUND & AIMS Although patients with cryptogenic cirrhosis have historically been considered ...
The incidence of hepatocellular carcinoma (HCC) in the United States is increasing, but the clinical...
Data on the long-term outcome of nonalcoholic steatohepatitis (NASH)-associated cirrhosis are few, a...
The objective of this study was to prospectively define outcomes of cirrhosis due to nonal-coholic s...
Recently, nonalcoholic steatohepatitis (NASH) has been considered to be another cause of liver cirrh...
Non-alcoholic steatohepatitis (NASH) has been associated with hepatocellular carcinoma (HCC) often a...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging stages of sev...
Background: Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging s...
Introduction. Epidemiological studies indicate that nonalcoholic steatohepatitis (NASH) is a common ...
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome ...
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome ...
Non-alcoholic steatohepatitis (NASH) is growing into global problem, mainly due to NASH-induced cirr...
Background. Nonalcoholic fatty liver disease (NAFLD) may develop into liver cirrhosis and hepatocell...
Recently, nonalcoholic steatohepatitis (NASH) has been considered to be another cause of liver cirrh...
BACKGROUND & AIMS Although patients with cryptogenic cirrhosis have historically been considered ...
The incidence of hepatocellular carcinoma (HCC) in the United States is increasing, but the clinical...